What will new weight loss medicines bring to people with type 2 diabetes?
While the new generation of available weight management medications are the most effective...
Read Moreby Dr. Sue Pedersen | Oct 5, 2026 | Media, Research, Uncategorized | 0
While the new generation of available weight management medications are the most effective...
Read Moreby Dr. Sue Pedersen | Sep 30, 2026 | Research, Uncategorized | 0
As blogged previously, the TRIUMPH-1 study of retatrutide demonstrated previously unsurpassed...
Read Moreby Dr. Sue Pedersen | Jul 17, 2026 | Research, Uncategorized | 0
Acquired hypothalamic obesity (AHO) is a rare and particularly challenging form of obesity to...
Read Moreby Dr. Sue Pedersen | Jun 13, 2026 | Research, Uncategorized | 0
As blogged previously, CagriSema is the first combination treatment of an amylin...
Read Moreby Dr. Sue Pedersen | Jun 11, 2026 | Research, Uncategorized | 0
As blogged previously, retatrutide ( a ‘triple G’ agonist of GLP1, GIP and glucagon)...
Read Moreby Dr. Sue Pedersen | Jun 11, 2026 | Research, Uncategorized | 0
As blogged previously, survodutide is a dual GLP1/glucagon receptor agonist that is being...
Read Moreby Dr. Sue Pedersen | May 18, 2026 | Research, Uncategorized | 0
When people achieve meaningful health benefits and weight loss with weight management medication,...
Read Moreby Dr. Sue Pedersen | May 18, 2026 | Research, Uncategorized | 0
For some people taking injectable GLP1 medications tirzepatide (Mounjaro/Zepbound) or semaglutide...
Read Moreby Dr. Sue Pedersen | Apr 14, 2026 | Research, Uncategorized | 0
Millions of people around the world are now taking the GLP1 medication semaglutide...
Read Moreby Dr. Sue Pedersen | Mar 11, 2026 | Research, Uncategorized | 0
While GLP1 weight management medications work well for many people, some struggle with...
Read Moreby Dr. Sue Pedersen | Mar 8, 2026 | Research, Uncategorized | 0
When humans lose weight with any currently available treatment (from lifestyle changes to obesity...
Read Moreby Dr. Sue Pedersen | Dec 12, 2025 | Media, Research, Uncategorized | 0
Listen here, or read below! Well this is exciting indeed! The topline results of the TRIUMPH-4...
Read More

I am a medical doctor, Specialist in Endocrinology & Metabolism, a Diplomate of the American Board of Obesity Medicine, and a Clinical Lecturer at the University of Calgary, Canada. After completing my training as an Endocrinologist in 2005 at the University of Calgary, I have worked in Calgary, at the Royal University Hospital in Saskatchewan, and at the University of Copenhagen in Denmark. I have a busy clinical practice at C-ENDO Diabetes and Endocrinology Clinic in Calgary, caring for patients with diabetes, obesity, thyroid, and other hormone issues. I am also involved in clinical research in diabetes and obesity. I am the lead author of the 2020 and 2022 Pharmacotherapy Chapters of the Canadian Obesity Clinical Practice Guidelines, and a member of the Expert Committee for the Diabetes Canada Clinical Practice Guidelines as an author on the Weight Management chapter. I am passionate, enthusiastic, and driven to help conquer the stigma against obesity; educate health care professionals and the public about obesity and diabetes; and to help us become a healthier society!